Daratumumab, Bortezomib, and Dexamethasone for treatment of patients with relapsed or refractory multiple myeloma and severe renal impairment: results from the phase 2 GMMG-DANTE t...
by Leypoldt, Lisa (Author)
, Gavriatopoulou, Maria (Author)
, Besemer, Britta (Author)
, Salwender, Hans (Author)
, Raab, Marc-Steffen (Author)
, Nogai, Axel (Author)
, Khandanpour, Cyrus (Author)
, Runde, Volker (Author)
, Jauch, Anna (Author)
, Zago, Manola (Author)
, Martus, Peter (Author)
, Goldschmidt, Hartmut (Author)
, Bokemeyer, Carsten (Author)
, Dimopoulos, Meletios A. (Author)
, Weisel, Katja C. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource